Study uncovers key processes behind MYC cancer gene
Researchers have discovered that MYC cancers use the cell’s machinery to make lipids and identified a lipid signature, which could be exploited in the development of new therapies.
List view / Grid view
Genomics is the branch of molecular biology concerned with the structure, function, evolution, and mapping of genomes.
Researchers have discovered that MYC cancers use the cell’s machinery to make lipids and identified a lipid signature, which could be exploited in the development of new therapies.
Researchers have discovered the mechanism behind the viral genome for measles, which could serve as a druggable target.
A new study has identified possible regulators that determine differences in cancer tumours between genders.
Two genes that influence risk Alzheimer's disease could provide scientists with new targets for delaying the onset of the condition's symptoms.
Researchers have successfully used a no-cut CRISPR gene editing technique as a therapy for muscular dystrophy in mice models.
Researchers have identified a key process behind senescence, or why cells age, which could be used to improve treatments for cancer.
Scientists have created the first completely artificial protein switch that can be ‘programmed’ to modify gene expression.
A study has used new synthetic lipids to deliver CRISPR gene editing tools into cells with up to 90 percent efficiency.
Researchers have generated images of CRISPR-Cas9 gene editing for the first time, enabling improvement of the technique.
New method for directed evolution could improve gene therapies and generic drug development.
Join the international [BC]2 conference and EMBO meeting at BASEL LIFE from 9–12 September: a unique opportunity for today’s scientists to get insights and share the latest discoveries, resources and approaches to make sense of genomic and health-related “big data” for molecular medicine – from precision oncology to infectious diseases.
A new study has used combined therapies to eliminate HIV from mice models, providing potential future cures.
Unique considerations surrounding the bureaucracy and oversight in the use of human biospecimens in the European Union.
High content data derived for complex immuno-oncology research facilitates a deeper understanding of the tissue microenvironment.